Align Technology, Inc. (NASDAQ:ALGN) Shares Bought by Natixis Advisors LLC

Natixis Advisors LLC increased its position in Align Technology, Inc. (NASDAQ:ALGN) by 71.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 31,996 shares of the medical equipment provider’s stock after acquiring an additional 13,342 shares during the period. Natixis Advisors LLC’s holdings in Align Technology were worth $6,671,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ALGN. Wellington Management Group LLP increased its holdings in shares of Align Technology by 49.0% in the 3rd quarter. Wellington Management Group LLP now owns 2,634,600 shares of the medical equipment provider’s stock worth $670,031,000 after acquiring an additional 866,663 shares during the period. Holocene Advisors LP acquired a new stake in shares of Align Technology in the 3rd quarter worth about $137,287,000. FMR LLC increased its holdings in shares of Align Technology by 43.0% in the 3rd quarter. FMR LLC now owns 1,221,831 shares of the medical equipment provider’s stock worth $310,736,000 after acquiring an additional 367,508 shares during the period. Point72 Asset Management L.P. increased its holdings in shares of Align Technology by 96.3% in the 3rd quarter. Point72 Asset Management L.P. now owns 674,319 shares of the medical equipment provider’s stock worth $171,493,000 after acquiring an additional 330,807 shares during the period. Finally, Meridiem Investment Management Ltd. increased its holdings in shares of Align Technology by 63.7% in the 4th quarter. Meridiem Investment Management Ltd. now owns 764,732 shares of the medical equipment provider’s stock worth $159,470,000 after acquiring an additional 297,472 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Align Technology in a report on Friday, February 14th. They issued an “overweight” rating and a $255.00 price objective on the stock. Leerink Partners upgraded shares of Align Technology from a “market perform” rating to an “outperform” rating and increased their target price for the company from $235.00 to $280.00 in a research report on Monday, January 6th. Leerink Partnrs upgraded shares of Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 6th. Mizuho assumed coverage on shares of Align Technology in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $295.00 target price for the company. Finally, Morgan Stanley decreased their target price on shares of Align Technology from $280.00 to $272.00 and set an “overweight” rating for the company in a research report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $266.73.

Align Technology Price Performance

Shares of ALGN opened at $168.81 on Friday. Align Technology, Inc. has a one year low of $158.13 and a one year high of $335.40. The company has a 50-day moving average of $199.65 and a two-hundred day moving average of $217.11. The stock has a market cap of $12.42 billion, a price-to-earnings ratio of 30.09, a PEG ratio of 2.24 and a beta of 1.69.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. Analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.